Corrigendum to "Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors" [Eur. J. Med. Chem. 44 (2009) 1830-1837] (DOI:10.1016/j.ejmech.2008.10.039);Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors

European Journal of Medicinal Chemistry

Volumn 44, Issue 5, 2009, Pages 1830-1837

  Dündar, Yasemin ^a   Ünlü, Serdar ^a   Banoǧlu, Erden ^a   Entrena, Antonio ^b   Costantino, Gabriele ^c   Nunez, Maria Teresa ^d   Ledo, Francisco ^d   Şahin, M Fethi ^a   Noyanalpan, Ningur ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Facultad de Farmacia   (Spain)

^c UNIVERSITY OF PARMA   (Italy)

^d FAES FARMA SA   (Spain)

Author keywords

4,5 Diphenyloxazolone; COX 1; COX 2; Cyclooxygenase inhibition; Docking

Indexed keywords

4 (4 PHENYL 3 METHYL 2 OXO 3H 1,3 OXAZOL 5 YL)BENZENSULFONAMIDE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; INDOMETACIN; MECLOFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; UNCLASSIFIED DRUG; VALDECOXIB;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; IC 50; MOLECULAR DOCKING;

EID: 62549162166     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.05.020     Document Type: Erratum

References (34)

1. Vane J.R., and Botting R.M. Am. J. Med. 104 3A (1998) 2S-8S discussion 21S-22S
2. Vane J.R., Bakhle Y.S., and Botting R.M. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
3. Simmons D.L., Botting R.M., and Hla T. Pharmacol. Rev. 56 3 (2004) 387-437
4. van Ryn J., Trummlitz G., and Pairet M. Curr. Med. Chem. 7 11 (2000) 1145-1161
5. Coruzzi G., Venturi N., and Spaggiari S. Acta Biomed. 78 2 (2007) 96-110
6. Mitchell J.A., and Warner T.D. Nat. Rev. Drug Discov. 5 1 (2006) 75-86
7. Fitzgerald G.A. N. Engl. J. Med. 351 17 (2004) 1709-1711
8. Funk C.D., and Fitzgerald G.A. J. Cardiovasc. Pharmacol. 50 5 (2007) 470-479
9. FitzGerald G.A. Nat. Rev. Drug Discov. 2 11 (2003) 879-890
10. Patrignani P., Tacconelli S., Sciulli M.G., and Capone M.L. Brain Res. Brain Res. Rev. 48 2 (2005) 352-359
11. Breinig M., Schirmacher P., and Kern M.A. Curr. Pharm. Des. 13 32 (2007) 3305-3315
12. Aparicio Gallego G., Diaz Prado S., Jimenez Fonseca P., Garcia Campelo R., Cassinello Espinosa J., and Anton Aparicio L.M. Clin. Transl. Oncol. 9 11 (2007) 694-702
13. van Gool W.A., Aisen P.S., and Eikelenboom P. J. Neurol. 250 7 (2003) 788-792
14. Aisen P.S., Schafer K.A., Grundman M., Pfeiffer E., Sano M., Davis K.L., Farlow M.R., Jin S., Thomas R.G., and Thal L.J. JAMA 289 21 (2003) 2819-2826
15. Zarghi A., Praveen Rao P.N., and Knaus E.E. Bioorg. Med. Chem. 15 2 (2007) 1056-1061
16. Palomer A., Cabre F., Pascual J., Campos J., Trujillo M.A., Entrena A., Gallo M.A., Garcia L., Mauleon D., and Espinosa A. J. Med. Chem. 45 7 (2002) 1402-1411
17. Kalgutkar A.S., Crews B.C., Saleh S., Prudhomme D., and Marnett L.J. Bioorg. Med. Chem. 13 24 (2005) 6810-6822
18. Kalgutkar A.S., Marnett A.B., Crews B.C., Remmel R.P., and Marnett L.J. J. Med. Chem. 43 15 (2000) 2860-2870
19. Kalgutkar A.S., Rowlinson S.W., Crews B.C., and Marnett L.J. Bioorg. Med. Chem. Lett. 12 4 (2002) 521-524
20. Gomper R. Chem. Ber. 89 7 (1956) 1748-1762
21. Hakimelahi G.H., Boyce C.B., and Kasmai H.S. Helv. Chim. Acta 60 2 (1977) 342-347
22. Dey A.S., and Neumeyer J.L. J. Med. Chem. 17 10 (1974) 1095-1100
23. Ninomiya I., Furutani I., Yamamato O., Kiguchi T., and Naito T. Heterocycles 9 7 (1978) 853-857
24. Sheehan J.C., and Guziec F.S. J. Am. Chem. Soc. 94 18 (1972) 6561-6562
25. Sheehan J.C., and Guziec F.S. J. Org. Chem. 38 17 (1973) 3034-3040
26. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., and Otomo S. Prostaglandins 47 1 (1994) 55-59
27. Janusz J.M., Young P.A., Ridgeway J.M., Scherz M.W., Enzweiler K., Wu L.I., Gan L., Darolia R., Matthews R.S., Hennes D., Kellstein D.E., Green S.A., Tulich J.L., Rosario-Jansen T., Magrisso I.J., Wehmeyer K.R., Kuhlenbeck D.L., Eichhold T.H., Dobson R.L., Sirko S.P., and Farmer R.W. J. Med. Chem. 41 7 (1998) 1112-1123
28. Patrignani P., Panara M.R., Greco A., Fusco O., Natoli C., Iacobelli S., Cipollone F., Ganci A., Creminon C., Maclouf J., et al. J. Pharmacol. Exp. Ther. 271 3 (1994) 1705-1712
29. Roy K., Chakraborty S., and Saha A. Bioorg. Med. Chem. Lett. 13 21 (2003) 3753-3757
30. Puig C., Crespo M.I., Godessart N., Feixas J., Ibarzo J., Jimenez J.M., Soca L., Cardelus I., Heredia A., Miralpeix M., Puig J., Beleta J., Huerta J.M., Lopez M., Segarra V., Ryder H., and Palacios J.M. J. Med. Chem. 43 2 (2000) 214-223
31. Kalgutkar A.S., Crews B.C., Rowlinson S.W., Marnett A.B., Kozak K.R., Remmel R.P., and Marnett L.J. Proc. Natl. Acad. Sci. U.S.A. 97 2 (2000) 925-930
32. M. Ohtani, T. Kato, PCT Int. Appl. WO 95 10,508 (Cl. C07D263/38), 20 Apr 1995; JP Appl. 93/258,309, 15 Oct 1993.
33. Greenberg H., Es T.V., and Backeberg O.G. J. Org. Chem. 32 10 (1967) 2964-2965
34. Brooks P., Emery P., Evans J.F., Fenner H., Hawkey C.J., Patrono C., Smolen J., Breedveld F., Day R., Dougados M., Ehrich E.W., Gijon-Baños J., Kvien T.K., Van Rijswijk M.H., Warner T., and Zeidler H. Rheumatology (Oxford) 38 8 (1999) 779-788